Pitting one bad actor against another, scientists are enlisting a virus to take on cancer. Tests in animals and some limited trials in patients have suggested that the technology could be effective. But before the trials progressed to their final phases, drug companies cooled to the idea and set the approach aside.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.